BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Eisai Establishes Pharmaceuticals Marketing Subsidiary in India

8th November 2004 Tokyo (JCNN) - Eisai (TSE: 4523) has announced the establishment of a pharmaceuticals marketing subsidiary, Eisai Pharmaceuticals India Private Ltd. in India.

The new subsidiary will sell and promote pharmaceuticals developed by Eisai including ARICEPT , an Alzheimer's disease treatment, and Aciphex/Pariet, a proton pump inhibitor, and other pharmaceuticals.

The pharmaceutical market is growing rapidly in India, and in 2005, a system for drug substance patents will be established.
 
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.